Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Talking Therapeutics

Talking Therapeutics
A Watershed Moment for Weight Loss
11/22/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this week's issue, Dr Jennings discusses the rates of obesity and how GLP-1 agonists may be vital in treating patients with obesity who have cardiovascular disease.
In this week's issue, Dr Jennings discusses the rates of obesity and how GLP-1 agonists may be vital in treating patients with obesity who have cardiovascular disease.
In this week's issue, Dr...
11/22/2023
Pharmacy Learning Network
Talking Therapeutics
The End of the Aspirin Era in Left Ventricular Assist Devices
11/16/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this week’s issue, Dr Jennings discusses the ARIES-HM3 trial, which explores the inclusion of aspirin with a vitamin-K antagonist for prosthetic heart valves.
In this week’s issue, Dr Jennings discusses the ARIES-HM3 trial, which explores the inclusion of aspirin with a vitamin-K antagonist for prosthetic heart valves.
In this week’s issue, Dr...
11/16/2023
Pharmacy Learning Network
Talking Therapeutics
Another Win for GLP-1 Agonists
11/08/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings reviews the latest new on the potential for the GLP-1 agonists to slow the progression of CKD in patients with diabetes.
Dr Jennings reviews the latest new on the potential for the GLP-1 agonists to slow the progression of CKD in patients with diabetes.
Dr Jennings reviews the latest...
11/08/2023
Pharmacy Learning Network
Talking Therapeutics
Cefepime vs Piperacillin-Tazobactam for Hospital-Acquired Infection
11/04/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this week’s issue, we discuss the ACORN study, which compared the outcomes of cefepime vs pip-tazo in patients with hospital-acquired infections.
In this week’s issue, we discuss the ACORN study, which compared the outcomes of cefepime vs pip-tazo in patients with hospital-acquired infections.
In this week’s issue, we discuss...
11/04/2023
Pharmacy Learning Network
Talking Therapeutics
A New Breakthrough In Anticoagulation
09/26/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
"Most patients with atrial fibrillation require life-long anticoagulation to prevent stroke, which exposes them to a significant cumulative risk for major hemorrhage, says Dr Jennings. "While most of the bleeding episodes that these patients...
"Most patients with atrial fibrillation require life-long anticoagulation to prevent stroke, which exposes them to a significant cumulative risk for major hemorrhage, says Dr Jennings. "While most of the bleeding episodes that these patients...
"Most patients with atrial...
09/26/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
A New Game Changer for HFpEF
09/06/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
This week, Dr Jennings reviews a new study that evaluated the effect of semaglutide in patients categorized as obese with heart failure with a preserved ejection fraction.
This week, Dr Jennings reviews a new study that evaluated the effect of semaglutide in patients categorized as obese with heart failure with a preserved ejection fraction.
This week, Dr Jennings reviews a...
09/06/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
More Evidence for the Heart-Gut Axis
08/29/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings discusses a new paper that explores the relationship between the gut microbiome and subclinical progression of atherosclerosis.
Dr Jennings discusses a new paper that explores the relationship between the gut microbiome and subclinical progression of atherosclerosis.
Dr Jennings discusses a new...
08/29/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
A New Win for Reducing CV Disease In HIV
08/15/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings explores the implications of recent research that shows statins, such as pitavastatin, could be a potential standard of care for patients with HIV and low to moderate risk factors for ASCVD, regardless of their serum LDL values.
Dr Jennings explores the implications of recent research that shows statins, such as pitavastatin, could be a potential standard of care for patients with HIV and low to moderate risk factors for ASCVD, regardless of their serum LDL values.
Dr Jennings explores the...
08/15/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
It Takes Two to Tango When Lowering Lipids After Percutaneous Coronary Intervention
08/01/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings discusses research showing a combination of rosuvastatin and ezetimibe could decrease the incidence of major adverse cardiovascular events in patients with atherosclerotic cardiovascular disease who received percutaneous coronary...
Dr Jennings discusses research showing a combination of rosuvastatin and ezetimibe could decrease the incidence of major adverse cardiovascular events in patients with atherosclerotic cardiovascular disease who received percutaneous coronary...
Dr Jennings discusses research...
08/01/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Small Targets Equal Big Gains for Treating Hypertension
07/26/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings walks through a study on zilebesiran, an investigational small interfering RNA therapy, for the treatment of patients with hypertension.
Dr Jennings walks through a study on zilebesiran, an investigational small interfering RNA therapy, for the treatment of patients with hypertension.
Dr Jennings walks through a...
07/26/2023
Pharmacy Learning Network

Meet the Author

Dr Jennings is currently an Associate Professor of Pharmacy at Long Island University and the clinical pharmacist for the Heart Transplant and LVAD teams at New York- Presbyterian Hospital Columbia University Irving Medical Center.
He is an active researcher in his field, and he has published over 120 peer-reviewed abstracts and manuscripts, primarily focusing on the pharmacotherapy of patients under mechanical circulatory support.
As a recognized expert in this area, he has been invited to speak at numerous national and international venues, including meetings in France, Saudia Arabia, and India.
Finally, Dr Jennings has been active in professional organizations throughout his career. He is a fellow of the American College of Clinical Pharmacy, the American College of Cardiology, the Heart Failure Society of America, and the AHA.

Advertisement

Additional Insights

Identifying the Important Role Pharmacists Play Among Patients Delaying PCP Care During the Pandemic
Videos
Identifying the Important Role Pharmacists Play Among Patients Delaying PCP Care During the Pandemic
11/10/2020
Andrea Russo, MD, director, Electrophysiology and Arrhythmia Services, Cooper Hospital, discusses why there have been delays among patients making primary care visits, along with the impact this has on diagnosis, and she provides tips for...
Andrea Russo, MD, director, Electrophysiology and Arrhythmia Services, Cooper Hospital, discusses why there have been delays among patients making primary care visits, along with the impact this has on diagnosis, and she provides tips for...
Andrea Russo, MD, director,...
11/10/2020
Pharmacy Learning Network
Exploring Prescribing Rates of Combination Therapy for BP Control
Videos
Exploring Prescribing Rates of Combination Therapy for BP Control
07/08/2020
Julie Johnson, PharmD, and Oyunbileg Magvanjav, MD, PhD, discuss the results of their recent study that explores the relationship between prescribing rates of guideline-recommended antihypertensive drug classes and blood pressure control.
Julie Johnson, PharmD, and Oyunbileg Magvanjav, MD, PhD, discuss the results of their recent study that explores the relationship between prescribing rates of guideline-recommended antihypertensive drug classes and blood pressure control.
Julie Johnson, PharmD, and...
07/08/2020
Pharmacy Learning Network
Association Between Blood Pressure Levels, Racial Disparities in Later-Life Cognitive Decline
Videos
Association Between Blood Pressure Levels, Racial Disparities in Later-Life Cognitive Decline
06/17/2020
Deborah Levine, MD, MPH, breaks down her recent study and explains why black individuals with a higher blood pressure level may be linked to racial disparities in cognitive decline.
Deborah Levine, MD, MPH, breaks down her recent study and explains why black individuals with a higher blood pressure level may be linked to racial disparities in cognitive decline.
Deborah Levine, MD, MPH, breaks...
06/17/2020
Pharmacy Learning Network
Is Warfarin Beneficial in Reducing Ischemic Stroke Incidence in Patients With AF, End-Stage Renal Disease?
Videos
Is Warfarin Beneficial in Reducing Ischemic Stroke Incidence in Patients With AF, End-Stage Renal Disease?
05/04/2020
Mandeep S Randhawa, MD, division of cardiology, Michigan State University, discusses his recent study and explains why warfarin provides no benefit for ischemic stroke incidence or mortality, as well as increase the risk of hemorrhagic...
Mandeep S Randhawa, MD, division of cardiology, Michigan State University, discusses his recent study and explains why warfarin provides no benefit for ischemic stroke incidence or mortality, as well as increase the risk of hemorrhagic...
Mandeep S Randhawa, MD, division...
05/04/2020
Pharmacy Learning Network
Videos
Acute Coronary Syndromes
06/25/2015
At a regional Pharmacy Learning Network meeting, Dr. Jean Nappi sat down with Dr. Randolph Fugit to discuss acute coronary syndromes.
At a regional Pharmacy Learning Network meeting, Dr. Jean Nappi sat down with Dr. Randolph Fugit to discuss acute coronary syndromes.
At a regional Pharmacy Learning...
06/25/2015
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement